# Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

> **NCT00614120** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 929 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** placebo
- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** glimepiride
- **DRUG:** metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00614120
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 929 (ACTUAL)
- **Last updated:** 2017-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614120, "Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00614120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*